Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: InHEART does not list a price
Free plan
Tie
Neither has one
Higher rating
PathAI
4.2 against 4.3
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
InHEART
PathAI
Our rating
4.2
4.3Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
AI segmentation of CT and MRI scans into interactive 3D heart models
24-hour turnaround from scan submission to delivered model
FDA 510(k)-cleared AI software for cardiac image segmentation
Ablation-strategy planning tools for electrophysiologists
Risk screening for heart failure, sudden cardiac death, and cardio-embolic stroke
AISight Dx analyzes digital pathology slide images to assist diagnosis
FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
Predetermined Change Control Plan allows faster future software updates
Expanded Labcorp collaboration deploying nationwide as of February 2026
FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
Pros
FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
Founding team combines AI/cardiac-modeling and practicing-physician expertise directly
$15.2M in funding, including an $11M Series A, supports continued clinical development
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Predetermined Change Control Plan speeds up future regulatory-approved updates
National-scale deployment through Labcorp validates real clinical trust
Cons
No public pricing; adoption requires a hospital procurement and contracting process
Narrow clinical focus (cardiac ablation and risk screening) versus broader cardiology AI suites
24-hour model turnaround may not fit urgent or same-day procedural planning
Enterprise quote-based pricing requires a sales conversation, no published rates
Built specifically for pathology labs, not applicable to other clinical specialties
Regulatory-cleared medical device status means slower iteration than software-only tools
Company
inHEART, founded 2017
PathAI, founded 2016
Prices come from each vendor's pricing page, last checked 20260718. Check the vendor before you buy.
FAQ
Questions people ask
Is InHEART better than PathAI?
In our reviews InHEART scores 4.2 and PathAI scores 4.3. The better pick depends on the job. InHEART: InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
PathAI
InHEART
